title: HDL: bridging past and present with a look at the future.
abstract: Clinical and epidemiological studies have shown that HDLs, a class of plasma lipoproteins, heterogeneous in size and density, have an atheroprotective role attributed, for years, to their capacity to promote the efflux of cholesterol from activated cholesterol-loaded arterial macrophages. Recent studies, however, have recognized that the physical heterogeneity of HDLs is associated with multiple functions that involve both the protein and the lipid components of these particles. ApoA-I, quantitatively the major protein constituent, has an amphipathic structure suited for transport of lipids. It readily interacts with the ATP-binding cassette transporter ABCA1, the SR-B1 scavenger receptor; activates the enzyme lecithin-cholesterol acyl transferase (LCAT), which is critical for HDL maturation. It also has antioxidant and antiinflammatory properties, along with the HDL-associated enzymes paraoxonase, platelet activating factor acetylhydrolase (PAF), and glutathione peroxidase. Regarding the lipid moiety, an atheroprotective role has been recognized for lysosphingolipids, particularly sphingosine-1-phosphate (S1P). All of these atheroprotective functions are lost in the post-translational dependent dysfunctional plasma HDLs of subjects with systemic inflammation, coronary heart disease, diabetes, and chronic renal disease. The emerging notion that particle quality has more predictive power than quantity has stimulated further exploration of the HDL proteome, already revealing unsuspected pro- or antiatherogenic proteins/peptides associated with HDL.
authors: Department of Medicine, University of Chicago, MC5041, 5841 S. Maryland Ave., Chicago, IL 60637, USA. ascanu@medicine.bsd.uchicago.edu
authors: Angelo M
authors: AM
authors: Scanu
authors: Celina
authors: C
authors: Edelstein
mesh_terms: D016632:Apolipoprotein A-I / Q000737:chemistry*; D016633:Apolipoprotein A-II / Q000737:chemistry*; D050197:Atherosclerosis / Q000517:prevention & control; D006028:Glycosphingolipids / Q000378:metabolism; D006801:Humans; D008075:Lipoproteins, HDL / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D040901:Proteomics; D012996:Solutions / Q000737:chemistry
chemical_list: D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D006028:Glycosphingolipids; D008075:Lipoproteins, HDL; D010743:Phospholipids; D012996:Solutions